Related Experiment Videos
Tocolysis with nifedipine or beta-adrenergic agonists: a meta-analysis
V Tsatsaris1, D Papatsonis, F Goffinet
1Department of Obstetrics and Gynecology, Hôpital Saint-Antoine, 184 rue du Faubourg Saint Antoine, 75012 Paris, France.
Obstetrics and Gynecology
|May 5, 2001
Summary
Nifedipine is more effective than beta-agonists for tocolysis, significantly delaying delivery and improving neonatal outcomes. It also has fewer side effects, making it a preferred first-line treatment for preterm labor.
Area of Science:
- Obstetrics and Gynecology
- Pharmacology
- Neonatal Medicine
Background:
- Preterm labor necessitates tocolysis to delay birth and improve neonatal outcomes.
- Beta-adrenergic agonists have been commonly used for tocolysis.
- Nifedipine, a calcium channel blocker, has emerged as an alternative tocolytic agent.
Purpose of the Study:
- To compare the efficacy and safety of nifedipine versus beta-adrenergic agonists for tocolysis.
- To evaluate the impact on delivery delay, maternal side effects, and neonatal outcomes.
Main Methods:
- Systematic review and meta-analysis of randomized controlled trials.
- Included published and unpublished trials comparing nifedipine with beta-agonists for preterm labor.
- Searched multiple databases including MEDLINE, Embase, and Cochrane Library.
Main Results:
- Nifedipine was more effective in delaying delivery by at least 48 hours and beyond 34 weeks gestation.
- Significantly fewer treatment interruptions due to side effects with nifedipine.
- Nifedipine use resulted in better neonatal outcomes, including reduced respiratory distress syndrome and NICU admissions.
Conclusions:
- Nifedipine demonstrates superior efficacy and safety compared to beta-agonists for tocolysis.
- Nifedipine should be considered a first-line agent for managing preterm labor.